Long-duration anti-retroviral drug stock-outs put DR Congolese patients at risk

The long duration and high magnitude of HIV/AIDS drugs stock-outs at public health facilities in the Democratic Republic of Congo puts patients at higher risk of treatment interruption, developing anti-retroviral resistance, treatment failure, morbidity and mortality, a new research has revealed. In a new report that details the findings of a research that assessed the ["]

The post Long-duration anti-retroviral drug stock-outs put DR Congolese patients at risk appeared first on Outbreak News Today.